Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 12Terminated 2Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Colonic Neoplasms 1Blast Crisis 1

Interventions

trametinib 1ripretinib 1pazopanib 1nilotinib 1binimetinib 1Imatinib Mesylate 1High-Energy Shock Waves 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Gastrointestinal Stromal Tumors × nilotinib × Clear all
NCT01270893 2012-08-02

Tasigna Neoadjuvant Gastrointestinal Stromal Tumor (GIST)

M.D. Anderson Cancer Center

Phase 2 Withdrawn
GastrointestinalSarcoma

Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡